vs
Axogen, Inc.（AXGN）与BIOLIFE SOLUTIONS INC（BLFS）财务数据对比。点击上方公司名可切换其他公司
Axogen, Inc.的季度营收约是BIOLIFE SOLUTIONS INC的3.2倍（$59.9M vs $18.8M）。BIOLIFE SOLUTIONS INC净利率更高（58.9% vs -22.0%，领先80.9%）。BIOLIFE SOLUTIONS INC同比增速更快（24.3% vs 21.3%）。过去两年Axogen, Inc.的营收复合增速更高（20.3% vs 1.0%）
Axogen总部位于美国佛罗里达州阿拉楚阿，是外科解决方案提供商，专注开发周围神经损伤修复相关产品，涵盖人体组织移植物、神经连接器、软组织膜等，旗下AVANCE细胞移植技术可模拟人体神经结构，临床数据显示其产品帮助87%的周围神经损伤患者实现感觉与运动功能恢复，2013年完成1800万美元首次公开募股。
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
AXGN vs BLFS — 直观对比
营收规模更大
AXGN
是对方的3.2倍
$18.8M
营收增速更快
BLFS
高出3.1%
21.3%
净利率更高
BLFS
高出80.9%
-22.0%
两年增速更快
AXGN
近两年复合增速
1.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $59.9M | $18.8M |
| 净利润 | $-13.2M | $11.1M |
| 毛利率 | 74.1% | — |
| 营业利润率 | -16.3% | 7.2% |
| 净利率 | -22.0% | 58.9% |
| 营收同比 | 21.3% | 24.3% |
| 净利润同比 | -3023.6% | -11.1% |
| 每股收益（稀释后） | $-0.28 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXGNBLFS
| Q4 25 | $59.9M | $18.8M | ||
| Q3 25 | $60.1M | $28.1M | ||
| Q2 25 | $56.7M | $25.4M | ||
| Q1 25 | $48.6M | $23.9M | ||
| Q4 24 | $49.4M | $15.1M | ||
| Q3 24 | $48.6M | $21.4M | ||
| Q2 24 | $47.9M | $19.7M | ||
| Q1 24 | $41.4M | $18.4M |
净利润AXGNBLFS
| Q4 25 | $-13.2M | $11.1M | ||
| Q3 25 | $708.0K | $621.0K | ||
| Q2 25 | $579.0K | $-15.8M | ||
| Q1 25 | $-3.8M | $-448.0K | ||
| Q4 24 | $450.0K | $12.5M | ||
| Q3 24 | $-1.9M | $-1.7M | ||
| Q2 24 | $-1.9M | $-20.7M | ||
| Q1 24 | $-6.6M | $-10.2M |
毛利率AXGNBLFS
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 73.8% | — | ||
| Q1 24 | 78.8% | — |
营业利润率AXGNBLFS
| Q4 25 | -16.3% | 7.2% | ||
| Q3 25 | 3.2% | -0.3% | ||
| Q2 25 | 3.0% | -65.5% | ||
| Q1 25 | -3.4% | -5.1% | ||
| Q4 24 | 4.1% | 3.6% | ||
| Q3 24 | -0.6% | -2.0% | ||
| Q2 24 | -0.9% | -6.6% | ||
| Q1 24 | -11.0% | -17.9% |
净利率AXGNBLFS
| Q4 25 | -22.0% | 58.9% | ||
| Q3 25 | 1.2% | 2.2% | ||
| Q2 25 | 1.0% | -62.3% | ||
| Q1 25 | -7.9% | -1.9% | ||
| Q4 24 | 0.9% | 82.5% | ||
| Q3 24 | -3.8% | -8.0% | ||
| Q2 24 | -4.0% | -105.1% | ||
| Q1 24 | -16.0% | -55.4% |
每股收益（稀释后）AXGNBLFS
| Q4 25 | $-0.28 | $0.23 | ||
| Q3 25 | $0.01 | $0.01 | ||
| Q2 25 | $0.01 | $-0.33 | ||
| Q1 25 | $-0.08 | $-0.01 | ||
| Q4 24 | $-0.00 | $0.27 | ||
| Q3 24 | $-0.04 | $-0.04 | ||
| Q2 24 | $-0.04 | $-0.45 | ||
| Q1 24 | $-0.15 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.5M | $33.0M |
| 总债务越低越好 | $48.4M | $5.0M |
| 股东权益账面价值 | $128.8M | $371.9M |
| 总资产 | $221.7M | $405.9M |
| 负债/权益比越低杠杆越低 | 0.38× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资AXGNBLFS
| Q4 25 | $41.5M | $33.0M | ||
| Q3 25 | $35.8M | $29.5M | ||
| Q2 25 | $29.9M | $31.9M | ||
| Q1 25 | $22.1M | $66.9M | ||
| Q4 24 | $33.5M | $91.5M | ||
| Q3 24 | $24.5M | $24.0M | ||
| Q2 24 | $21.1M | $22.0M | ||
| Q1 24 | $17.6M | $29.7M |
总债务AXGNBLFS
| Q4 25 | $48.4M | $5.0M | ||
| Q3 25 | $48.2M | $7.5M | ||
| Q2 25 | $47.9M | $10.1M | ||
| Q1 25 | $47.7M | $12.9M | ||
| Q4 24 | $47.5M | $15.9M | ||
| Q3 24 | $47.3M | $20.1M | ||
| Q2 24 | $47.0M | $21.1M | ||
| Q1 24 | $46.8M | $24.3M |
股东权益AXGNBLFS
| Q4 25 | $128.8M | $371.9M | ||
| Q3 25 | $120.8M | $353.7M | ||
| Q2 25 | $112.3M | $347.2M | ||
| Q1 25 | $105.4M | $352.6M | ||
| Q4 24 | $103.9M | $348.9M | ||
| Q3 24 | $99.4M | $325.5M | ||
| Q2 24 | $95.7M | $321.4M | ||
| Q1 24 | $93.2M | $333.4M |
总资产AXGNBLFS
| Q4 25 | $221.7M | $405.9M | ||
| Q3 25 | $216.4M | $392.1M | ||
| Q2 25 | $205.5M | $387.2M | ||
| Q1 25 | $196.2M | $395.1M | ||
| Q4 24 | $203.7M | $399.5M | ||
| Q3 24 | $192.0M | $381.7M | ||
| Q2 24 | $188.9M | $375.0M | ||
| Q1 24 | $186.5M | $401.6M |
负债/权益比AXGNBLFS
| Q4 25 | 0.38× | 0.01× | ||
| Q3 25 | 0.40× | 0.02× | ||
| Q2 25 | 0.43× | 0.03× | ||
| Q1 25 | 0.45× | 0.04× | ||
| Q4 24 | 0.46× | 0.05× | ||
| Q3 24 | 0.48× | 0.06× | ||
| Q2 24 | 0.49× | 0.07× | ||
| Q1 24 | 0.50× | 0.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.0M | $4.9M |
| 自由现金流经营现金流 - 资本支出 | $1.8M | — |
| 自由现金流率自由现金流/营收 | 3.0% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.44× |
| 过去12个月自由现金流最近4个季度 | $-2.9M | — |
8季度趋势，按日历期对齐
经营现金流AXGNBLFS
| Q4 25 | $3.0M | $4.9M | ||
| Q3 25 | $3.2M | $6.1M | ||
| Q2 25 | $7.7M | $7.4M | ||
| Q1 25 | $-13.2M | $1.7M | ||
| Q4 24 | $8.7M | $1.6M | ||
| Q3 24 | $3.9M | $4.8M | ||
| Q2 24 | $4.2M | $6.5M | ||
| Q1 24 | $-12.3M | $-4.5M |
自由现金流AXGNBLFS
| Q4 25 | $1.8M | — | ||
| Q3 25 | $1.7M | — | ||
| Q2 25 | $7.0M | — | ||
| Q1 25 | $-13.4M | — | ||
| Q4 24 | $8.1M | — | ||
| Q3 24 | $3.3M | — | ||
| Q2 24 | $3.3M | — | ||
| Q1 24 | $-13.2M | — |
自由现金流率AXGNBLFS
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 12.4% | — | ||
| Q1 25 | -27.7% | — | ||
| Q4 24 | 16.3% | — | ||
| Q3 24 | 6.8% | — | ||
| Q2 24 | 6.8% | — | ||
| Q1 24 | -31.9% | — |
资本支出强度AXGNBLFS
| Q4 25 | 2.1% | — | ||
| Q3 25 | 2.5% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 1.4% | — | ||
| Q3 24 | 1.2% | — | ||
| Q2 24 | 1.9% | — | ||
| Q1 24 | 2.2% | — |
现金转化率AXGNBLFS
| Q4 25 | — | 0.44× | ||
| Q3 25 | 4.55× | 9.83× | ||
| Q2 25 | 13.35× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 19.41× | 0.13× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
